Healio

Relfydess earns positive opinion for treatment of frown lines, crow’s feet in EU

Please provide your email address to receive an email when new articles are posted on . Relfydess has received a positive decision for treatment of frown lines and crow’s feet in the European Union.
Yahoo

Soon, Robots — Not Doctors — Might Be Scanning Your Body For Skin Cancer

Add Yahoo as a preferred source to see more of our stories on Google. A world where a robot quickly scans your body for skin cancer or your forehead lines stay frozen with just a treatment or two a ...
Finanznachrichten

IMCAS 2025: New Galderma Phase IIIb Data Reinforce Rapid Onset and Long-lasting Aesthetic Improvement with RelabotulinumtoxinA (Relfydess)

First results from the phase IIIb RELAX clinical trial reinforce the high and sustained efficacy of single treatment of RelabotulinumtoxinA (Relfydess TM) for moderate to severe frown lines (glabellar ...
Mena FN

IMCAS 2025: Galderma's Broad Presence And New Data On Recently Launched Products Restylane® SHAYPETM And Relfydess® Reaff...

(BUSINESS WIRE )--Galderma will present the latest updates from its innovative aesthetics portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2025 on January 30 – ...
Mena FN

Christchurch Clinic Among First In New Zealand To Offer New Generation Anti-Wrinkle Treatment Relfydess

(MENAFN- EIN Presswire) EINPresswire/ -- Face Value Cosmetic Medicine Clinic in Christchurch has begun offering Relfydess, a new anti-wrinkle injectable treatment designed to deliver faster onset and ...
Financial Post

IMCAS 2025: Galderma's Broad Presence and New Data on Recently Launched Products Restylane® SHAYPE™ and Relfydess® Reaffirm Its Category Leadership

ZUG, Switzerland — Galderma will present the latest updates from its innovative aesthetics portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2025 on January 30 – ...